Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 6/20 | 0.58 |
| ▸ | MCHR1 | Q99705 | 7/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4387351 | 0.83 | PDE10A (0.55) | PDE10AMCHR1HDAC1HDAC2 | |
| SCHEMBL4388489 | 0.83 | PDE10A (0.79) | PDE10AMCHR1HDAC1HDAC2NQO2 | |
| SCHEMBL2840650 | 0.81 | PDE10A (0.63) | PDE10AMCHR1HDAC1HDAC2NQO2 | |
| SCHEMBL3277356 | 0.80 | PDE10A (0.61) | PDE10AMCHR1HDAC1HDAC2 | |
| SCHEMBL4389390 | 0.80 | PDE10A (0.70) | PDE10AMCHR1HDAC1HDAC2NQO2 | |
| SCHEMBL7453345 | 0.80 | PDE10A (0.61) | PDE10AMCHR1HDAC1HDAC2NQO2 | |
| SCHEMBL18682211 | 0.79 | PDE10A (0.68) | PDE10AMCHR1 | |
| SCHEMBL18199915 | 0.78 | CCR1 (0.50) | PDE10AMCHR1 | |
| Hydrochloric Acid SCHEMBL15023608 | 0.78 | PDE10A (0.56) | PDE10AMCHR1HDAC1HDAC2NQO2 | |
| SCHEMBL15865602 | 0.77 | METAP2 (0.53) | PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11008290-B2 | Halogenated quinoline derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-05-18 | — | — | US | disclosed |
| WO-2017053696-A2 | HALOGENATED QUINOLINE DERIVATIVES AS ANTIMICROBIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2017-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11008290-B2 | Halogenated quinoline derivatives as antimicrobial agents | NDUFS5, NDUFS7, NDUFS3 | PDE10A 2428/4885MCHR1 1219/4885HDAC1 678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.